These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35752155)

  • 1. Predictors of poor serologic response to COVID-19 vaccine in patients with cancer: a systematic review and meta-analysis.
    Yang W; Zhang D; Li Z; Zhang K
    Eur J Cancer; 2022 Sep; 172():41-50. PubMed ID: 35752155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.
    Becerril-Gaitan A; Vaca-Cartagena BF; Ferrigno AS; Mesa-Chavez F; Barrientos-Gutiérrez T; Tagliamento M; Lambertini M; Villarreal-Garza C
    Eur J Cancer; 2022 Jan; 160():243-260. PubMed ID: 34794855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
    Lee ARYB; Wong SY; Chai LYA; Lee SC; Lee MX; Muthiah MD; Tay SH; Teo CB; Tan BKJ; Chan YH; Sundar R; Soon YY
    BMJ; 2022 Mar; 376():e068632. PubMed ID: 35236664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety.
    Javadinia SA; Alizadeh K; Mojadadi MS; Nikbakht F; Dashti F; Joudi M; Harati H; Welsh JS; Farahmand SA; Attarian F
    Front Endocrinol (Lausanne); 2022; 13():860238. PubMed ID: 35586627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis.
    Mehrabi Nejad MM; Shobeiri P; Dehghanbanadaki H; Tabary M; Aryannejad A; Haji Ghadery A; Shabani M; Moosaie F; SeyedAlinaghi S; Rezaei N
    Virol J; 2022 Aug; 19(1):132. PubMed ID: 35941646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired serological response to COVID-19 vaccination following anticancer therapy: A systematic review and meta-analysis.
    Tang K; Wei Z; Wu X
    J Med Virol; 2022 Oct; 94(10):4860-4868. PubMed ID: 35750492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis.
    Zhou Q; Liu Y; Zeng F; Meng Y; Liu H; Deng G
    Vaccines (Basel); 2023 Apr; 11(4):. PubMed ID: 37112701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis.
    Yin J; Chen Y; Li Y; Zhang X; Wang C
    Hum Vaccin Immunother; 2022 Nov; 18(6):2119763. PubMed ID: 36161976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment.
    Buttiron Webber T; Provinciali N; Musso M; Ugolini M; Boitano M; Clavarezza M; D'Amico M; Defferrari C; Gozza A; Briata IM; Magnani M; Paciolla F; Menghini N; Marcenaro E; De Palma R; Sacchi N; Innocenti L; Siri G; D'Ecclesiis O; Cevasco I; Gandini S; DeCensi A
    Eur J Cancer; 2021 Dec; 159():105-112. PubMed ID: 34742157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis.
    Ma Y; Liu N; Wang Y; Zeng J; Hu YY; Hao W; Shi H; Zhu P; Lv J; Fan W; Wang X
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34845005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients.
    Schietzel S; Anderegg M; Limacher A; Born A; Horn MP; Maurer B; Hirzel C; Sidler D; Moor MB
    RMD Open; 2022 Feb; 8(1):. PubMed ID: 35115385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis.
    Yin J; Chen Y; Li Y; Wang C; Zhang X
    Int J Infect Dis; 2022 Nov; 124():212-223. PubMed ID: 36241168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare Workers and Nonhealthcare Workers Pro-Vaccination Attitude and Its Associated Factors towards COVID-19 Vaccine Globally: A Systematic Review and Meta-Analysis.
    Wake AD
    Interdiscip Perspect Infect Dis; 2022; 2022():2443785. PubMed ID: 36262688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis.
    Sakuraba A; Luna A; Micic D
    J Hematol Oncol; 2022 Feb; 15(1):15. PubMed ID: 35123511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients.
    Chen S; Wei W; Huang F; Wang J; Li X; Geng Z; Gao F; Dong T; Wei P; Yang X; Miao F
    Hum Vaccin Immunother; 2023 Dec; 19(1):2196893. PubMed ID: 37057765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis.
    Jena A; James D; Singh AK; Dutta U; Sebastian S; Sharma V
    Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1456-1479.e18. PubMed ID: 35189387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients.
    Sakuraba A; Luna A; Micic D
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis.
    Sakuraba A; Luna A; Micic D
    Gastroenterology; 2022 Jan; 162(1):88-108.e9. PubMed ID: 34599933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis.
    Tran S; Truong TH; Narendran A
    Eur J Cancer; 2021 Dec; 159():259-274. PubMed ID: 34798454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.